The independent source for health policy research, polling, and news.
1,061-1,080 of 1,293 results
Oral arguments got underway in federal court in Fort Worth, Texas, on Wednesday in the lawsuit brought by 20 Republican states seeking to declare the Affordable Care Act unconstitutional.
The Golden State, with the rare support of the Trump administration, is seeking to circumvent a court order that would require cancer warnings in every establishment that sells a hot cup of Joe.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
The Group Insurance Board reversed a decision made last year to bar coverage of transgender hormone therapy and surgery for public workers.
Shepherd Smith, a strong supporter of abstinence-only sex education for AIDS, has been close to the new director of the CDC for decades. This connection is just one example of the "new in crowd" surrounding the Trump administration, where politics and religion mix.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Alice Ollstein of Talking Points Memo, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about a spate of lawsuits involving the Affordable Care Act, as well as the latest in state and federal efforts regarding the Medicaid program for the poor.
Even as it chips away at Obamacare, the Trump administration is solidly behind state-based initiatives to cover high-cost patients, known as 鈥渞einsurance鈥 programs. It approved two more last month.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Instead of waiting for congressional action, federal regulators are looking at a series of actions to spur competition and drive down the cost of medicines.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about the latest Trump administration efforts to address high drug prices, what鈥檚 next for short-term health insurance plans and insider trading charges against a New York GOP congressman.
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
Under the Trump administration's new rule, these plans can now last as long as 12 months 鈥 instead of the Obama-era 90-day limit 鈥 and be renewed for two additional years. Critics say these changes are part of another swipe at the Affordable Care Act.
The administration says these plans, which can now last as long as 12 months and be renewed for two years, will give consumers another less-pricey insurance option. Critics say the new rule is yet another swipe at the Affordable Care Act.
The Trump administration signals it is willing to consider such a move if it is carefully tailored to focus solely on specific situations where a high-priced drug is made by one company.
The Trump administration says its plan to overhaul the way Medicare pays doctors will save physicians time and paperwork. But critics worry the changes will hurt patients' care and doctors' income.
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Kimberly Leonard of the Washington Examiner talk about the new push on health legislation by Republicans in the House, as well as developments on Medicaid work requirements, drug prices and the fate of children separated from their parents at the U.S.-Mexican border. Plus, for extra credit, the panelists offer their favorite health stories of the week.
Dramatic policy swings, from an unprecedented expansion of transgender rights under the Obama administration to the unpredictable reduction of trans rights under President Donald Trump, have left many trans Americans feeling the whiplash.
After a San Francisco speech focused mostly on Medicare, Seema Verma fielded questions that underscored the administration鈥檚 differences with California on other key health care issues.
Several major drugmakers vow to contain drug prices, but similar pledges since the 1990s have not had much impact.
漏 2026 KFF